Bladex, Inc. (BLX) Financials

BLX

FY2025 annual

Revenue $12.2M YoY not available

Net Income $226.9M YoY not available

EPS (Diluted) Not reported for FY2025

Operating Cash Flow $780.2M YoY not available

Market Cap $2.0B as of Oct 13, 2026

Price / Sales 167x on $12.2M revenue, FY2025

Price / Earnings 9.0x on $226.9M net income, FY2025

Price / Book 2.2x on $911.1M equity, Q3 FY2015

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Apr 20, 2026 Reported Apr 20, 2026 Currency USD FYE April

Newest figures come from the 20-F for FY2025, filed Apr 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BLX SEC filings page.

Bladex, Inc. (BLX) reported $12.2M in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BLX FY2025 2026-10-03

Modest returns on a large asset base coexist with a balance sheet financed mainly by liabilities rather than reported debt.

Operating cash flow of $780M was about 3.4x net income of $227M in FY2025. That gap suggests cash generation was influenced by balance-sheet movements in addition to reported earnings, making operating cash flow a less direct measure of underlying profitability.

ROA of 1.8% versus ROE of 13.5% shows a business producing modest profit per asset dollar but a higher return on shareholder capital because assets are funded substantially with liabilities. The model is therefore asset-intensive, even though equity returns appear stronger in isolation.

Total liabilities of $11.1B were paired with equity of $1.7B, while long-term debt was only $17M. The 0.01x debt-to-equity ratio therefore captures only one funding category and should not be read as the company’s overall balance-sheet leverage; the statements show a liability-heavy, not debt-heavy structure.

Financial Health Signals

Financial health score not available

Bladex, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

5/6

Bladex, Inc. passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

3.44x

For every $1 of reported earnings, Bladex, Inc. generates $3.44 in operating cash flow ($780.2M OCF vs $226.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q3 2015.

Cash & Balance Sheet

Cash & Debt

$741.3M

YoY-10.8%

QoQ-10.8%

Bladex, Inc. held $741.3M in cash against $761.6M in long-term debt as of Q3 2015.

Free Cash Flow

Not reported for Q3 2015.

Dividends Per Share

Not reported for Q3 2015.

Shares Outstanding

Not reported for Q3 2015.

Margins & Returns

None of these metrics is reported for Q3 2015.

Capital Allocation

None of these metrics is reported for Q3 2015.

BLX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BLX quarterly income statement

Metric	FY2520-F	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Revenue	$12.2M	$212.7M+3.6%	$205.3M+6.7%	$192.4M+22.2%	$157.4M+31.8%	$119.5M-15.8%	$142.0M
SG&A Expenses	N/A	$31.3M-1.1%	$31.7M-4.4%	$33.2M+19.2%	$27.8M+25.1%	$22.3M+10.1%	$20.2M
Operating Income	N/A	$115.0M+45.1%	$79.2M+4.3%	$76.0M-14.4%	$88.7M+156.8%	$34.5M	N/A
EBITDA	N/A	$117.5M+43.3%	$82.0M+4.8%	$78.3M-13.9%	$90.9M+145.5%	$37.0M	N/A
Interest Expense	$714K	$71.6M-12.9%	$82.2M-6.0%	$87.5M+59.8%	$54.7M+21.7%	$45.0M-41.8%	$77.2M
Net Income	$226.9M	$106.9M+26.2%	$84.8M-8.9%	$93.0M+11.8%	$83.2M+96.9%	$42.2M-23.0%	$54.9M
EPS (Basic)	N/A	$2.76+24.9%	$2.21-10.2%	$2.46+9.3%	$2.25+95.7%	$1.15-23.3%	$1.50
EPS (Diluted)	N/A	$2.75+25.0%	$2.20-10.2%	$2.45+9.4%	$2.24+94.8%	$1.15-23.3%	$1.50
Diluted Shares (Avg)	37M	39M+0.8%	39M+1.6%	38M+2.1%	37M+100799.1%	36,814-99.9%	37M

Metric	Q3'1510-K	Q3'1410-K	Q3'1310-K	Q3'1210-K	Q3'1110-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

BLX Balance Sheet

BLX quarterly balance sheet

Metric	FY2520-F	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Total Assets	$12.8B	$8.0B+7.4%	$7.5B+10.6%	$6.8B+6.2%	$6.4B+24.7%	$5.1B	N/A
Cash & Equivalents	$1.8B	$741.3M-10.8%	$830.7M+20.0%	$692.5M-12.3%	$789.5M+87.7%	$420.6M+4.6%	$402.0M
Short-Term Investments	N/A	$0	$0	$0	$0	$0	$0
Accounts Receivable	N/A	$4.3M+182.8%	$1.5M-13.4%	$1.7M+38.8%	$1.3M	N/A	N/A
Long-Term Investments	N/A	$0	$0	$0	$0	$0	$0
Total Liabilities	$11.1B	$7.1B+8.4%	$6.6B+10.7%	$5.9B+5.9%	$5.6B+27.6%	$4.4B	N/A
Long-Term Debt	$17.0M	$761.6M+22.3%	$622.5M+2.5%	$607.3M+1231.4%	$45.6M-95.8%	$1.1B	N/A
Total Equity	$1.7B	$911.1M+6.2%	$858.0M+3.8%	$826.5M+8.8%	$759.3M+8.9%	$697.0M+3.2%	$675.6M
Retained Earnings	$916.4M	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'1510-K	Q3'1410-K	Q3'1310-K	Q3'1210-K	Q3'1110-K
Total Assets	$8.0B+7.4%	$7.5B+10.6%	$6.8B+6.2%	$6.4B+24.7%	$5.1B
Cash & Equivalents	$741.3M-10.8%	$830.7M+20.0%	$692.5M-12.3%	$789.5M+87.7%	$420.6M
Short-Term Investments	$0	$0	$0	$0	$0
Accounts Receivable	$4.3M+182.8%	$1.5M-13.4%	$1.7M+38.8%	$1.3M	N/A
Long-Term Investments	$0	$0	$0	$0	$0
Total Liabilities	$7.1B+8.4%	$6.6B+10.7%	$5.9B+5.9%	$5.6B+27.6%	$4.4B
Long-Term Debt	$761.6M+22.3%	$622.5M+2.5%	$607.3M+1231.4%	$45.6M-95.8%	$1.1B
Total Equity	$911.1M+6.2%	$858.0M+3.8%	$826.5M+8.8%	$759.3M+8.9%	$697.0M

Not reported in any period shown, so not listed: Current Assets, Inventory, Goodwill, Current Liabilities, Non-Current Liabilities, Retained Earnings.

BLX Cash Flow Statement

BLX quarterly cash flow statement

Metric	FY2520-F	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Operating Cash Flow	$780.2M	$170.5M+212.4%	$54.6M-43.8%	$97.1M-46.1%	$180.2M+161.0%	$69.0M+295.2%	$17.5M
Depreciation & Amortization	N/A	$2.5M-9.5%	$2.7M+21.1%	$2.3M+6.1%	$2.1M-13.4%	$2.5M	N/A
Stock-Based Compensation	N/A	$2.2M-25.0%	$3.0M+31.9%	$2.3M-1.7%	$2.3M+10.1%	$2.1M+31.5%	$1.6M
Capital Expenditures	N/A	$150K-68.5%	$476K-95.6%	$10.8M+387.5%	$2.2M+73.3%	$1.3M-47.7%	$2.5M
Free Cash Flow	N/A	$170.3M+214.9%	$54.1M-37.3%	$86.3M-51.5%	$178.0M+162.7%	$67.8M+351.1%	$15.0M
Investing Cash Flow	-$211.2M	-$604.9M-0.6%	-$601.6M-19.4%	-$503.8M+49.9%	-$1.0B+17.9%	-$1.2B-1269.9%	$104.8M
Financing Cash Flow	-$546.8M	$345.1M-49.6%	$685.2M+121.1%	$309.8M-74.1%	$1.2B+1.7%	$1.2B+315.3%	-$545.8M
Dividends Paid	$91.8M	$54.3M+17.9%	$46.0M+15.9%	$39.7M+34.6%	$29.5M+29.9%	$22.7M-34.3%	$34.6M
Share Buybacks	N/A	$640K+2270.4%	$27K	$0	$0-100.0%	$3K	N/A

Metric	Q3'1510-K	Q3'1410-K	Q3'1310-K	Q3'1210-K	Q3'1110-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

BLX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BLX quarterly financial ratios

Metric	FY2520-F	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K	FY0910-K
Operating Margin	N/A	54.0%+15.4pp	38.6%-0.9pp	39.5%-16.9pp	56.4%+27.4pp	28.9%	N/A
Net Margin	1858.9%	50.3%+9.0pp	41.3%-7.1pp	48.3%-4.5pp	52.8%+17.5pp	35.4%-3.3pp	38.6%
Return on Equity	13.5%	11.7%+1.9pp	9.9%-1.4pp	11.3%+0.3pp	11.0%+4.9pp	6.1%-2.1pp	8.1%
Return on Assets	1.8%	1.3%+0.2pp	1.1%-0.3pp	1.4%+0.1pp	1.3%+0.5pp	0.8%	N/A
Debt-to-Equity	0.01	0.84+0.1x	0.730.0x	0.73+0.7x	0.06-1.5x	1.54	N/A
Asset Turnover	0.00	0.030.0x	0.030.0x	0.030.0x	0.020.0x	0.02	N/A
FCF Margin	N/A	80.0%+53.7pp	26.3%-18.5pp	44.8%	113.1%	56.7%+46.1pp	10.6%

Metric	Q3'1510-K	Q3'1410-K	Q3'1310-K	Q3'1210-K	Q3'1110-K
Debt-to-Equity	0.84+0.1x	0.730.0x	0.73+0.7x	0.06-1.5x	1.54

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Current Ratio, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Bladex, Inc. BLX	FY2025	$12.2M	$226.9M	N/A	$2.0B	—
Northwest Bancshares, Inc NWBI	FY2025	$654.7M	$126.0M	19.3%	$2.2B	48/100
First Commonwealth Financial Corporation FCF	FY2025	$522.9M	$152.3M	29.1%	$2.0B	63/100
City Holding Co CHCO	FY2025	$314.2M	$130.5M	41.5%	$2.0B	59/100
Pathward Financial, Inc. CASH	FY2025	$839.9M	$185.9M	22.1%	$1.5B	55/100
OFG BANCORP OFG	FY2025	$731.4M	$205.1M	28.0%	$2.1B	56/100

Where Bladex, Inc. Ranks

Frequently Asked Questions

What is Bladex, Inc.'s annual revenue?

Bladex, Inc. (BLX) reported $12.2M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Bladex, Inc. profitable?

Yes, Bladex, Inc. (BLX) reported a net income of $226.9M in fiscal year 2025.

How much debt does Bladex, Inc. have?

As of fiscal year 2025, Bladex, Inc. (BLX) had $1.8B in cash and equivalents against $17.0M in long-term debt.

What is Bladex, Inc.'s return on equity (ROE)?

Bladex, Inc. (BLX) has a return on equity of 13.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Bladex, Inc.'s operating cash flow?

Bladex, Inc. (BLX) generated $780.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Bladex, Inc.'s total assets?

Bladex, Inc. (BLX) had $12.8B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Bladex, Inc. have outstanding?

Bladex, Inc. (BLX) had 6M shares outstanding as of fiscal year 2025.

What is Bladex, Inc.'s debt-to-equity ratio?

Bladex, Inc. (BLX) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Bladex, Inc.'s return on assets (ROA)?

Bladex, Inc. (BLX) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Bladex, Inc.'s P/E ratio?

Bladex, Inc. (BLX) trades at 9.0x earnings, its market capitalization divided by net income of $226.9M net income, FY2025. The market capitalization is $2.0B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Bladex, Inc.'s price-to-sales ratio?

Bladex, Inc. (BLX) trades at 167x sales, its market capitalization divided by revenue of $12.2M revenue, FY2025. The market capitalization is $2.0B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Bladex, Inc.'s Piotroski F-Score?

Bladex, Inc. (BLX) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Bladex, Inc.'s earnings high quality?

Bladex, Inc. (BLX) has an earnings quality ratio of 3.44x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.